# Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

> **NCT06590896** · PHASE2 · RECRUITING · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 100 (estimated)

## Conditions studied

- Epilepsies, Partial

## Interventions

- **DRUG:** Cenobamate

## Key facts

- **NCT ID:** NCT06590896
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-04
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06590896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06590896, "Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06590896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*